Infection and integration of human papillomavirus in esophageal carcinoma

International Journal of Hygiene and Environmental Health

Volumn 214, Issue 2, 2011, Pages 156-161

  Zhang, Qing Ying ^a   Zhang, Dong Hong ^a   Shen, Zhong Ying ^a   Xu, Li Yan ^a   Li, En Min ^a   Au, William W ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Esophageal carcinoma; Genotyping; HPV integration; Human papillomavirus; Nested PCR

Indexed keywords

VIRUS DNA;

ADULT; AGE; AGED; ARTICLE; CASE CONTROL STUDY; CHINA; ESOPHAGUS; ESOPHAGUS TUMOR; FEMALE; GENETICS; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PATHOGENICITY; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; SQUAMOUS CELL CARCINOMA; VIROLOGY; VIRUS DNA CELL DNA INTERACTION;

ADULT; AGE FACTORS; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHINA; DNA, VIRAL; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; VIRUS INTEGRATION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 79953043388     PISSN: 14384639     EISSN: 1618131X     Source Type: Journal    
DOI: 10.1016/j.ijheh.2010.11.001     Document Type: Article

References (44)

1. Badaracco G., Venuti A., Sedati A., Marcante M.L. HPV16 and HPV18 in genital tumors: significantly different levels of viral integration and correlation to tumor invasiveness. J. Med. Virol. 2002, 67:574-582.
2. Bjorge T., Hakulinen T., Engeland A., Jellum E., Koskela P., Lehtinen M., Luostarinen T., Paavonen J., Sapp M., Schiller J. A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway. Cancer Res. 1997, 57:3989-3992.
3. Bodaghi S., Yamanegi K., Xiao S.Y., Da C.M., Palefsky J.M., Zheng Z.M. Colorectal papillomavirus infection in patients with colorectal cancer. Clin. Cancer Res. 2005, 11:2862-2867.
4. Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., Benbrahim-Tallaa L., Guha N., Freeman C., Galichet L., Cogliano V. A review of human carcinogens - Part B: biological agents. Lancet Oncol. 2009, 10:321-322.
5. Chang F., Syrjanen S., Shen Q., Cintorino M., Santopietro R., Tosi P., Syrjanen K. Human papillomavirus involvement in esophageal carcinogenesis in the high-incidence area of China. A study of 700 cases by screening and type-specific in situ hybridization. Scand. J. Gastroenterol. 2000, 35:123-130.
6. Cao B., Tian X., Li Y., Jiang P., Ning T., Xing H., Zhao Y., Zhang C., Shi X., Chen D., Shen Y., Ke Y. LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in China. Carcinogenesis 2005, 26:1280-1284.
7. Couturier J., Sastre-Garau X., Schneider-Maunoury S., Labib A., Orth G. Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto-oncogene expression. J. Virol. 1991, 65:4534-4538.
8. de Villiers E.M., Lavergne D., Chang F., Syrjänen K., Tosi P., Cintorino M., Santopietro R., Syrjänen S. An interlaboratory study to determine the presence of human papillomavirus DNA in esophageal carcinoma from China. Int. J. Cancer 1999, 81:225-228.
9. de Villiers E.M., Gunst K., Stein H., Scherubl H. Esophageal squamous cell cancer in patients with head and neck cancer: prevalence of human papillomavirus DNA sequences. Int. J. Cancer 2004, 109:253-258.
10. Dreilich M., Bergqvist M., Moberg M., Brattstrom D., Gustavsson I., Bergstrom S., Wanders A., Hesselius P., Wagenius G., Gyllensten U. High-risk human papilloma virus (HPV) and survival in patients with esophageal carcinoma: a pilot study. BMC Cancer 2006, 6:1-7.
11. Far A.E., Aghakhani A., Hamkar R., Ramezani A., Pishbigar H.F., Mirmomen S., Roshan M.R., Vahidi S., Shahnazi V., Deljoodokht Z. Frequency of human papillomavirus infection in oesophageal squamous cell carcinoma in Iranian patients. Scand. J. Infect. Dis. 2007, 39:58-62.
12. Gillison M.L., Koch W.M., Capone R.B., Spafford M., Westra W.H., Wu L., Zahurak M.L., Daniel R.W., Viglione M., Symer D.E., Shah K.V., Sidransky D. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 2000, 92:709-720.
13. IARC Monographs Evaluation of Carcinogenic Risks to Humans. Volume 100B: A Review of Human Carcinogens Biological agents 2009, IARC, Lyon, France.
14. Kalantari M., Karlsen F., Kristensen G., Holm R., Hagmar B., Johansson B. Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis. Int. J. Gynecol. Pathol. 1998, 17:146-153.
15. Kamangar F., Qiao Y.L., Schiller J.T., Dawsey S.M., Fears T., Sun X.D., Abnet C.C., Zhao P., Taylor P.R., Mark S.D. Human papillomavirus serology and the risk of esophageal and gastric cancers: results from a cohort in a high-risk region in China. Int. J. Cancer 2006, 119:579-584.
16. Koshiol J., Wei W.Q., Kreimer A.R., Chen W., Gravitt P., Ren J.S., Abnet C.C., Wang J.B., Kamangar F., Lin D.M., von Knebel-Doeberitz M., Zhang Y., Viscidi R., Wang G.Q., Gillison M.L., Roth M.J., Dong Z.W., Kim E., Taylor P.R., Qiao Y.L., Dawsey S.M. No role for human papillomavirus in esophageal squamous cell carcinoma in China. Int. J. Cancer 2009, 16. (Epub ahead of print).
17. Matsha T., Donninger H., Erasmus R.T., Hendricks D., Stepien A., Parker M.I. Expression of p53 and its homolog, p73, in HPV DNA positive oesophageal squamous cell carcinomas. Virology 2007, 369:182-190.
18. Matsha T., Erasmus R., Kafuko A.B., Mugwanya D., Stepien A., Parker M.I. Human papillomavirus associated with oesophageal cancer. J. Clin. Pathol. 2002, 55:587-590.
19. Odze R., Antonioli D., Shocket D., Noble-Topham S., Goldman H., Upton M. Esophageal squamous papillomas. A clinicopathologic study of 38 lesions and analysis for human papillomavirus by the polymerase chain reaction. Am. J. Surg. Pathol. 1993, 17:803-812.
20. Orlowska J., Jarosz D., Gugulski A., Pachlewski J., Butruk E. Squamous cell papillomas of the esophagus: report of 20 cases and literature review. Am. J. Gastroenterol. 1994, 89:434-437.
21. Pantelis A., Pantelis D., Ruemmele P., Hartmann A., Hofstaedter F., Buettner R., Bootz F., Stoehr R. p53 codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohort. Oncol. Rep. 2007, 17:1243-1248.
22. Peitsaro P., Johansson B., Syrjanen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J. Clin. Microbiol. 2002, 40:886-891.
23. Poljak M., Cerar A., Seme K. Human papillomavirus infection in esophageal carcinomas: a study of 121 lesions using multiple broad-spectrum polymerase chain reactions and literature review. Hum. Pathol. 1998, 29:266-271.
24. Qi Z.L., Huo X., Xu X.J., Zhang B., Du M.G., Yang H.W., Zheng L.K., Li J., Shen Z.Y. Relationship between HPV16/18 E6 and 53, 21WAF1, MDM2, Ki67 and cyclin D1 expression in esophageal squamous cell carcinoma: comparative study by using tissue microarray technology. Exp. Oncol. 2006, 28:235-240.
25. Ringstrom E., Peters E., Hasegawa M., Posner M., Liu M., Kelsey K.T. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin. Cancer Res. 2002, 8:3187-3192.
26. Ritchie J.M., Smith E.M., Summersgill K.F., Hoffman H.T., Wang D., Klussmann J.P., Turek L.P., Haugen T.H. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int. J. Cancer. 2003, 104:336-344.
27. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990, 63:1129-1136.
28. Si H.X., Tsao S.W., Poon C.S., Wang L.D., Wong Y.C., Cheung A.L. Viral load of HPV in esophageal squamous cell carcinoma. Int. J. Cancer. 2003, 103:496-500.
29. Si H.X., Tsao S.W., Poon C.S., Wong Y.C., Cheung A.L. Physical status of HPV-16 in esophageal squamous cell carcinoma. J. Clin. Virol. 2005, 32:19-23.
30. Shen Z.Y., Hu S.P., Lu L.C., Tang C.Z., Kuang Z.S., Zhong S.P., Zeng Y. Detection of human papillomavirus in esophageal carcinoma. J. Med. Virol. 2002, 68:412-416.
31. Shuyama K., Castillo A., Aguayo F., Sun Q., Khan N., Koriyama C., Akiba S. Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China. Br. J. Cancer 2007, 96:1554-1559.
32. Su M., Liu M., Tian D.P., Li X.Y., Zhang G.H., Yang H.L., Fan X., Huang H.H., Gao Y.X. Temporal trends of esophageal cancer during 1995-2004 in Nanao Island, an extremely high-risk area in China. Eur. J. Epidemiol. 2007, 22:43-48.
33. Syrjanen K., Pyrhonen S., Aukee S., Koskela E. Squamous cell papilloma of the esophagus: a tumour probably caused by human papilloma virus (HPV). Diagn. Histopathol. 1982, 5:291-296.
34. Syrjanen K.J. HPV infections and oesophageal cancer. J. Clin. Pathol. 2002, 55:721-728.
35. Tornesello M.L., Monaco R., Nappi O., Buonaguro L., Buonaguro F.M. Detection of mucosal and cutaneous human papillomaviruses in oesophagitis, squamous cell carcinoma and adenocarcinoma of the oesophagus. J. Clin. Virol. 2009, 45:28-33.
36. Trottier H., Mahmud S., Costa M.C., Sobrinho J.P., Duarte-Franco E., Rohan T.E., Ferenczy A., Villa L.L., Franco E.L. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol. Biomarkers Prev. 2006, 15:1274-1280.
37. Turner J.R., Shen L.H., Crum C.P., Dean P.J., Odze R.D. Low prevalence of human papillomavirus infection in esophageal squamous cell carcinomas from North America: analysis by a highly sensitive and specific polymerase chain reaction-based approach. Hum. Pathol. 1997, 28:174-178.
38. Umar S.B., Fleischer D.E. Esophageal cancer: epidemiology, pathogenesis and prevention. Nat. Clin. Pract. Gastroenterol. Hepatol. 2008, 5:517-526.
39. van Doornum G.J., Korse C.M., Buning-Kager J.C., Bonfrer J.M., Horenblas S., Taal B.G., Dillner J. Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites. Br. J. Cancer 2003, 88:1095-1100.
40. Vernon S.D., Unger E.R., Miller D.L., Lee D.R., Reeves W.C. Association of human papillomavirus type 16 integration in the E2 gene with poor disease-free survival from cervical cancer. Int. J. Cancer 1997, 74:50-56.
41. Wang X., Tian X., Liu F., Zhao Y., Sun M., Chen D., Lu C., Wang Z., Shi X., Zhang Q., Zhang D., Shen Z., Li F., Harris C.C., Cai H., Ke Y. Detection of HPV DNA in esophageal cancer specimens from different regions and ethnic groups: a descriptive study. BMC Cancer 2010, 10:1-7.
42. Wei J.T., Shaheen N. The changing epidemiology of esophageal adenocarcinoma. Semin. Gastrointest. Dis. 2003, 14:112-127.
43. Yao P.F., Li G.C., Li J., Xia H.S., Yang X.L., Huang H.Y., Fu Y.G., Wang R.Q., Wang X.Y., Sha J.W. Evidence of human papilloma virus infection and its epidemiology in esophageal squamous cell carcinoma. World J. Gastroenterol. 2006, 12:1352-1355.
44. Zhuang J., Yu X., Dong J., Li M. Detection of human papillomavirus DNA sequence in esophageal carcinoma using polymerase chain reaction. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 1997, 11:150-152.